IsoRay’s Liquid Cesium-131 (Cesitrex(R)) Recieves Final Regulatory Approval for Use in GliaSite(R) Brain Cancer Treatment System

IsoRay’s Liquid Cesium-131 (Cesitrex(R)) Recieves Final Regulatory Approval for Use in GliaSite(R) Brain Cancer Treatment System

[Marketwired] – IsoRay Inc. , a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced Isoray has received final approval from the State of Washington Department … more

View todays social media effects on ISR

View the latest stocks trending across Twitter. Click to view dashboard

See who IsoRay is hiring next, click here to view

Share this post